These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


652 related items for PubMed ID: 8787478

  • 1. Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension.
    Curran RD, Mavroudis C, Backer CL, Sautel M, Zales VR, Wessel DL.
    Ann Thorac Surg; 1995 Dec; 60(6):1765-71. PubMed ID: 8787478
    [Abstract] [Full Text] [Related]

  • 2. Inhaled prostacyclin following surgical repair of congenital heart disease--a pilot study.
    Carroll CL, Backer CL, Mavroudis C, Cook K, Goodman DM.
    J Card Surg; 2005 Dec; 20(5):436-9. PubMed ID: 16153274
    [Abstract] [Full Text] [Related]

  • 3. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N, Lundin S, Ricksten SE.
    J Heart Lung Transplant; 1995 Dec; 14(3):436-43. PubMed ID: 7654728
    [Abstract] [Full Text] [Related]

  • 4. Effects of inhaled nitric oxide in patients with hypoxemia and pulmonary hypertension after cardiac surgery.
    Bender KA, Alexander JA, Enos JM, Skimming JW.
    Am J Crit Care; 1997 Mar; 6(2):127-31. PubMed ID: 9172849
    [Abstract] [Full Text] [Related]

  • 5. Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease.
    Lee JE, Hillier SC, Knoderer CA.
    J Intensive Care Med; 2008 Mar; 23(5):329-34. PubMed ID: 18701525
    [Abstract] [Full Text] [Related]

  • 6. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease.
    Schulze-Neick I, Hartenstein P, Li J, Stiller B, Nagdyman N, Hübler M, Butrous G, Petros A, Lange P, Redington AN.
    Circulation; 2003 Sep 09; 108 Suppl 1():II167-73. PubMed ID: 12970227
    [Abstract] [Full Text] [Related]

  • 7. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.
    Santini F, Casali G, Franchi G, Auriemma S, Lusini M, Barozzi L, Favaro A, Messina A, Mazzucco A.
    Int J Cardiol; 2005 Aug 18; 103(2):156-63. PubMed ID: 16080974
    [Abstract] [Full Text] [Related]

  • 8. Does inhaled nitric oxide improve survival in operated congenital disease with severe pulmonary hypertension?
    Sharma R, Raizada N, Choudhary SK, Bhan A, Kumar P, Juneja R, Kothari SS, Saxena A, Venugopal P.
    Indian Heart J; 2001 Aug 18; 53(1):48-55. PubMed ID: 11456141
    [Abstract] [Full Text] [Related]

  • 9. [Improvement of perioperative hemodynamics and gas exchange by inhalation of nitric oxide in children with congenital cardiopulmonary defects].
    Breuer J, von Brenndorff CI, Baden W, Sieverding L, Steil E, Häberle L, Fenchel G, Apitz J.
    Z Kardiol; 1995 Dec 18; 84(12):1009-17. PubMed ID: 8578785
    [Abstract] [Full Text] [Related]

  • 10. Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease.
    Limsuwan A, Khosithseth A, Wanichkul S, Khowsathit P.
    Catheter Cardiovasc Interv; 2009 Jan 01; 73(1):98-104. PubMed ID: 19089967
    [Abstract] [Full Text] [Related]

  • 11. Low doses of inhaled nitric oxide in heart transplant recipients.
    Auler Júnior JO, Carmona MJ, Bocchi EA, Bacal F, Fiorelli AI, Stolf NA, Jatene AD.
    J Heart Lung Transplant; 1996 May 01; 15(5):443-50. PubMed ID: 8771498
    [Abstract] [Full Text] [Related]

  • 12. Inhaled nitric oxide: effects on hemodynamics, myocardial contractility, and regional blood flow in dogs with mechanically induced pulmonary artery hypertension.
    Girard C, Fargnoli JM, Godin-Ribuot D, Dutheil V, Maitrasse B, Girardet P, Arvieux CC.
    J Heart Lung Transplant; 1996 Jul 01; 15(7):700-8. PubMed ID: 8820786
    [Abstract] [Full Text] [Related]

  • 13. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
    Khan TA, Schnickel G, Ross D, Bastani S, Laks H, Esmailian F, Marelli D, Beygui R, Shemin R, Watson L, Vartapetian I, Ardehali A.
    J Thorac Cardiovasc Surg; 2009 Dec 01; 138(6):1417-24. PubMed ID: 19931670
    [Abstract] [Full Text] [Related]

  • 14. Inhaled nitric oxide as therapy for pulmonary hypertension in postoperative cases of congenital heart defects.
    Murthy KS, Rao SG, Prakash KS, Punnoose A, Benjamin N, Bharati AS, Singh RK, Cherian KM.
    Indian Heart J; 1996 Dec 01; 48(6):695-8. PubMed ID: 9062021
    [Abstract] [Full Text] [Related]

  • 15. [Management of postoperative pulmonary hypertensive crisis in children--indication and usefulness of inhaled nitric oxide therapy as a pulmonary vasodilator].
    Atsumi N, Gomi S, Kanemoto S, Mihara W, Shigeta O, Terada Y, Jikuya T, Sakakibara Y, Mitsui T, Ninomiya H.
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Dec 01; 44(12):2123-9. PubMed ID: 8990884
    [Abstract] [Full Text] [Related]

  • 16. Acute effect of oral prostacyclin and inhaled nitric oxide on pulmonary hypertension in children.
    Ichida F, Uese K, Hashimoto I, Hamamichi Y, Tsubata S, Fukahara K, Murakami A, Miyawaki T.
    J Cardiol; 1997 Apr 01; 29(4):217-24. PubMed ID: 9127838
    [Abstract] [Full Text] [Related]

  • 17. [The effects of inhaled nitric oxide on pulmonary vascular resistance in patients after total cavopulmonary connection].
    Yin ZT, Zhu HY, Zhang RF, Zhang NB, Wang ZW, Gong HD, Wang J, Song HC.
    Zhonghua Wai Ke Za Zhi; 2005 May 15; 43(10):647-9. PubMed ID: 16008934
    [Abstract] [Full Text] [Related]

  • 18. Inhaled nitric oxide reduction in systolic pulmonary artery pressure is less in patients with decreased left ventricular ejection fraction.
    Cujec B, Hurst T, McCuaig R, Antecol D, Mayers I, Johnson D.
    Can J Cardiol; 1997 Sep 15; 13(9):816-24. PubMed ID: 9343030
    [Abstract] [Full Text] [Related]

  • 19. [Pulmonary hypertension in pediatric heart surgery].
    Falcone N.
    Rev Esp Anestesiol Reanim; 2001 Dec 15; 48(10):462-4. PubMed ID: 11792301
    [Abstract] [Full Text] [Related]

  • 20. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
    Evgenov OV, Ichinose F, Evgenov NV, Gnoth MJ, Falkowski GE, Chang Y, Bloch KD, Zapol WM.
    Circulation; 2004 Oct 12; 110(15):2253-9. PubMed ID: 15466650
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 33.